English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 8, 2026

City Therapeutics raises $99.5 million to advance RNAi pipeline and platform
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Kailera Therapeutics advances obesity drug after record IPO and new study results
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Researchers report PCAIs show promise against KRAS-driven pancreatic cancer in new study
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Incyte announces $2 billion acquisition of Vega Therapeutics for blood disorder drug
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Study examines link between menstrual cycle phase and COVID-19 vaccine side effects
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Rice University receives CPRIT funding to advance cancer research
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Frailty linked to poorer blood pressure control in older women, study finds
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

Texas A&M researchers develop AI-designed molecular switch controlled by caffeine

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns